# COL6A5

## Overview
The COL6A5 gene encodes the collagen type VI alpha 5 chain, a structural protein that is part of the collagen VI family, which plays a critical role in the extracellular matrix (ECM) of connective tissues. This protein is involved in forming microfibrillar networks that contribute to the mechanical strength and elasticity of tissues such as cartilage, bone, and skin. The collagen type VI alpha 5 chain is characterized by its complex structure, including multiple von Willebrand factor A domains and a collagen triple helix, which facilitate its interactions with other collagen VI chains to form heterotrimers. These interactions are essential for maintaining tissue integrity and facilitating cellular adhesion and signaling. The gene's expression is notably high in dermal papillae, where it supports ECM-cell interactions and tissue resilience. Mutations in COL6A5 have been linked to various clinical conditions, including Chiari Malformation Type 1 and certain cancers, underscoring its significance in human health and disease (Urbizu2021Rare; Caputo2020RNAseqBased).

## Structure
The COL6A5 gene encodes the collagen type VI alpha 5 chain, a component of the extracellular matrix. The protein is composed of 2611 amino acids and has a predicted molecular mass of 287 kDa (Fitzgerald2008Three). The primary structure includes a signal peptide at the N-terminus, followed by seven N-terminal von Willebrand factor A (VWA) domains, a 336-amino acid collagen triple helix, and three C-terminal VWA domains (Fitzgerald2008Three). The triple helix contains several imperfections in the Gly-X-Y repeat motif, where the Gly residue is substituted by another amino acid at specific positions (Fitzgerald2008Three). 

The α5(VI) chain also features a single RGD cell-binding signal and specific cysteine residues that contribute to its structure (Fitzgerald2008Three). The protein can form heterotrimers with other collagen VI chains, such as α1 and α2, although it may not always co-assemble with these chains (Fitzgerald2008Three). The human COL6A5 gene produces full-length α5 chain isoforms of 2526, 2614, or 2615 amino acids due to alternative splicing, resulting in different C termini (Gara2008Three). The α5(VI) chain is similar to the α3(VI) chain, as indicated by phylogenetic analysis (Fitzgerald2008Three).

## Function
The COL6A5 gene encodes the collagen type VI alpha 5 chain, a component of the extracellular matrix (ECM) that plays a crucial role in maintaining tissue structure and function. In healthy human cells, COL6A5 is primarily expressed in the dermal papillae within the dermo-epidermal junctions, where it is involved in cellular adhesion processes and ECM-cell interactions (Caputo2020RNAseqBased). This protein contributes to the formation and maintenance of structural components, providing mechanical strength and elasticity to connective tissues such as cartilage, bone, epidermis, cornea, and blood vessels (Caputo2020RNAseqBased).

COL6A5 is implicated in several molecular pathways, including focal adhesion and the PI3K/AKT pathways, which influence cell survival and proliferation (Caputo2020RNAseqBased). These pathways are essential for maintaining cell homeostasis and the structural integrity of various tissues. The protein's involvement in ECM organization and cell adhesion underscores its role in tissue resilience and function (Urbizu2021Rare). The ECM, composed of protein fibers like collagens, is vital for the structure and function of connective tissues, including bones and ligaments, highlighting the importance of COL6A5 in maintaining overall tissue health (Urbizu2021Rare).

## Clinical Significance
Mutations and alterations in the COL6A5 gene have been implicated in several diseases and conditions. In Chiari Malformation Type 1 (CM-1), rare functional genetic variants in COL6A5 are frequently observed. These variants are associated with a higher burden of CM-1 cases, suggesting a significant role in the risk for this condition. The study highlights that 25.8% of CM-1 cases presented rare variants in COL6A5, indicating its potential impact on CM-1 pathogenesis (Urbizu2021Rare).

In the context of psoriasis (Ps) and psoriatic arthritis (PsA), the SNP rs12488457 in COL6A5 has been identified as a susceptibility biomarker. This SNP is associated with both conditions, potentially affecting protein function and contributing to the etiopathogenesis of Ps and PsA (Caputo2020RNAseqBased).

COL6A5 variations have also been linked to lung cancer risk in the Chinese Han population. Specific SNPs, such as rs13062453 and rs1497305, are associated with an increased risk of lung adenocarcinoma and lung squamous cell carcinoma. These findings suggest that COL6A5 polymorphisms may serve as risk markers for lung cancer, highlighting the gene's role in lung tumorigenesis and prognosis (Duan2020Collagen).

## Interactions
COL6A5, a member of the collagen VI family, is involved in forming a microfibrillar network within the extracellular matrix. It interacts with other collagen VI chains, such as COL6A1, COL6A2, and COL6A3, to form heterotrimeric molecules that contribute to tissue integrity and cellular functions, including cell adhesion and signaling (Ma2023Differential). Protein-protein interaction (PPI) network analysis has indicated that COL6A5, along with other COL6 genes, shows moderate to high correlation in expression, suggesting potential interactions among these proteins (Ma2023Differential). 

In the context of Chiari Malformation Type 1 (CM-1), COL6A5 has been highlighted for its potential involvement in the pathogenesis of the condition. A PPI network analysis using the STRING database revealed a statistically significant enrichment of interactions among proteins associated with CM-1 and Ehlers-Danlos Syndrome, indicating a potential biological connection involving COL6A5 (Urbizu2021Rare). Although specific protein interactions involving COL6A5 are not detailed, the gene is implicated in processes such as collagen fibril organization and extracellular matrix organization, which are crucial for maintaining structural integrity in tissues (Urbizu2021Rare).


## References


1. (Ma2023Differential) Differential expression of COL6 family is a potential tumor marker for predicting gastric cancer. This article has 0 citations.

[2. (Caputo2020RNAseqBased) Valerio Caputo, Claudia Strafella, Andrea Termine, Elena Campione, Luca Bianchi, Giuseppe Novelli, Emiliano Giardina, and Raffaella Cascella. Rnaseq-based prioritization revealed col6a5, col8a1, col10a1 and mir146a as common and differential susceptibility biomarkers for psoriasis and psoriatic arthritis: confirmation from genotyping analysis of 1417 italian subjects. International Journal of Molecular Sciences, 21(8):2740, April 2020. URL: http://dx.doi.org/10.3390/ijms21082740, doi:10.3390/ijms21082740. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21082740)

[3. (Fitzgerald2008Three) Jamie Fitzgerald, Cathleen Rich, Fiona H. Zhou, and Uwe Hansen. Three novel collagen vi chains, α4(vi), α5(vi), and α6(vi). Journal of Biological Chemistry, 283(29):20170–20180, July 2008. URL: http://dx.doi.org/10.1074/jbc.M710139200, doi:10.1074/jbc.m710139200. This article has 206 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M710139200)

[4. (Duan2020Collagen) Ying Duan, Gaowen Liu, Yao Sun, Jiamin Wu, Zichao Xiong, Tianbo Jin, and Mingwei Chen. Collagen type vi α5 gene variations may predict the risk of lung cancer development in chinese han population. Scientific Reports, March 2020. URL: http://dx.doi.org/10.1038/s41598-020-61614-x, doi:10.1038/s41598-020-61614-x. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-61614-x)

[5. (Urbizu2021Rare) Aintzane Urbizu, Melanie E. Garrett, Karen Soldano, Oliver Drechsel, Dorothy Loth, Anna Marcé-Grau, Olga Mestres i Soler, Maria A. Poca, Stephan Ossowski, Alfons Macaya, Francis Loth, Rick Labuda, and Allison Ashley-Koch. Rare functional genetic variants in col7a1, col6a5, col1a2 and col5a2 frequently occur in chiari malformation type 1. PLOS ONE, 16(5):e0251289, May 2021. URL: http://dx.doi.org/10.1371/journal.pone.0251289, doi:10.1371/journal.pone.0251289. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0251289)

[6. (Gara2008Three) Sudheer Kumar Gara, Paolo Grumati, Anna Urciuolo, Paolo Bonaldo, Birgit Kobbe, Manuel Koch, Mats Paulsson, and Raimund Wagener. Three novel collagen vi chains with high homology to the α3 chain. Journal of Biological Chemistry, 283(16):10658–10670, April 2008. URL: http://dx.doi.org/10.1074/jbc.M709540200, doi:10.1074/jbc.m709540200. This article has 215 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M709540200)